We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TV Spot on EpiPen Pulled After FDA Warning Letter
TV Spot on EpiPen Pulled After FDA Warning Letter
June 8, 2012
Pfizer agreed to pull a 60-second direct-to-consumer (DTC) TV ad promoting a pair of drug-device combination products to treat severe allergic reactions after the FDA flagged it for overstating the products’ efficacy.